(Q37622879)

21 August 2017

1 reference

title

Predicting response to radiotherapy: evolutions and revolutions (English)

1 reference

adaptive radiation therapy

21 August 2017

main subject

0 references

author name string

Adrian C Begg

series ordinal

1

1 reference

21 August 2017

publication date

1 January 2009

1 reference

International Journal of Radiation Biology

21 August 2017

published in

1 reference

21 August 2017

volume

85

1 reference

21 August 2017

issue

10

1 reference

21 August 2017

page(s)

825-836

1 reference

Genetic regulators of large-scale transcriptional signatures in cancer

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Genetic markers for prediction of normal tissue toxicity after radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Genomic location analysis by ChIP-Seq

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Ki67 protein: the immaculate deception?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Targeting cancer cells by synthetic lethality: autophagy and VHL in cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Use of the Oncotype DX 21-gene assay to guide adjuvant decision making in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Adjuvant endocrine therapy for premenopausal women with early breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Facts and controversies in the use of trastuzumab in the adjuvant setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Converting a breast cancer microarray signature into a high-throughput diagnostic test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Recurrent genomic alterations with impact on survival in colorectal cancer identified by genome-wide array comparative genomic hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Systematic review: gene expression profiling assays in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Potential molecular prognostic markers in head and neck squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Radiation-induced gene expression in human subcutaneous fibroblasts is predictive of radiation-induced fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Commercialized multigene predictors of clinical outcome for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Survivin depletion preferentially reduces the survival of activated K-Ras-transformed cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Development of the 21-gene assay and its application in clinical practice and clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Analysis of gene expression using gene sets discriminates cancer patients with and without late radiation toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Prediction of radiation sensitivity using a gene expression classifier

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Hypoxia in cancer: significance and impact on clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Prostate bed localization with image-guided approach using on-board imaging: reporting acute toxicity and implications for radiation therapy planning following prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Invited review: intrinsic radiosensitivity as a predictor of patient response to radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Techniques used in studies of age-related DNA methylation changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Proteomics: methodologies and applications in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

A method for analyzing censored survival phenotype with gene expression data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

MicroRNA signature predicts survival and relapse in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Growth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903184366

10.1080/09553000903184366

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference